| NET LOSS PER SHARE |
NET LOSS PER SHARE Basic and diluted net loss per share attributable to common stockholders was calculated as follows: | | | | | | | | | | | | | | | | | | | | | | Fiscal Year Ended March 31 | | | 2026 | | 2025 | | 2024 | | Numerator: | | | | | | | | Net loss | | $ | (39,008) | | | $ | (32,878) | | | $ | (37,010) | | | | | | | | | | Net loss attributable to common stockholders—basic and diluted | | $ | (39,008) | | | $ | (32,878) | | | $ | (37,010) | | | Denominator: | | | | | | | | Weighted average common shares outstanding—basic and diluted | | 8,542,502 | | | 8,719,978 | | | 8,863,029 | | | | | | | | | | Net loss per share attributable to common stockholders - basic and diluted | | $ | (4.57) | | | $ | (3.77) | | | $ | (4.18) | | For the fiscal years ended March 31, 2026, 2025 and 2024, the Company’s potential dilutive securities, which include stock options, RSUs, warrants and convertible notes have been excluded from the computation of diluted net loss per share as the effect would be to reduce the net loss per share. Therefore, the weighted-average number of shares of common stock outstanding used to calculate both basic and diluted net loss per share attributable to common stockholders is the same for each of the fiscal years ended March 31, 2026, 2025 and 2024. The Company excluded the following potential shares of common stock, presented based on amounts outstanding at March 31, 2026, 2025 and 2024 from the computation of diluted net loss per share attributable to common stockholders for the fiscal years ended March 31, 2026, 2025 and 2024 because including them would have had an anti-dilutive effect. | | | | | | | | | | | | | | | | | | | | | | As of | | | March 31, | | | 2026 | | 2025 | | 2024 | | | | | | | | | | Stock options to purchase common stock | 431,333 | | | 498,137 | | | 605,695 | | | | Restricted stock units | 968,864 | | | 848,750 | | | 613,899 | | | | Warrants to purchase common stock | 651,817 | | | 651,817 | | | 651,817 | | | 2025 Convertible Notes as converted to common stock | — | | | 218,328 | | | 206,946 | | | Employee stock purchase plan | 14,033 | | | 7,615 | | | 14,817 | | |
The Company also had convertible notes outstanding for the fiscal year ended March 31, 2026, which could have obligated the Company and/or its stockholders to issue shares of common stock upon the occurrence of various future events at prices and in amounts that are not determinable until the occurrence of those future events. Since the necessary conditions for the conversion of these instruments had not been satisfied during the fiscal year ended March 31, 2026, the Company excluded these instruments from the table above and the calculation of diluted net loss per share for the period. See Note 6, “Debt,” for additional details.
|